Ayala Pharmaceuticals Total Non Current Liabilities 2011-2026 | AYLA

Annual Total Non Current Liabilities Ayala Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	553 K	299 K	46.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
46.2 M	299 K	15.7 M

Quarterly Total Non Current Liabilities Ayala Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	396 K	414 K	472 K	497 K	493 K	502 K	505 K	553 K	553 K	553 K	553 K	299 K	299 K	299 K	299 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
553 K	299 K	446 K

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	604 M	$ 309.95	0.48 %	$ 40.6 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	131 M	-	-	$ 866 M	China
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Adagene ADAG	158 M	$ 2.92	2.46 %	$ 164 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.85	-	$ 4.64 M	China
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Anavex Life Sciences Corp. AVXL	332	$ 4.04	3.06 %	$ 345 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.51	-	$ 8.45 B	Australia
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	101 M	$ 217.14	-0.44 %	$ 5 B	Danmark
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Biogen BIIB	9.03 B	$ 196.65	0.59 %	$ 28.8 B	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Bristol-Myers Squibb Company BMY	59.9 B	$ 60.28	0.7 %	$ 123 B	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
BioNTech SE BNTX	341 M	$ 107.17	1.33 %	$ 27.2 B	Germany
Autolus Therapeutics plc AUTL	50.6 M	$ 1.41	2.09 %	$ 360 M	Britain
Amneal Pharmaceuticals AMRX	2.42 B	$ 14.67	0.27 %	$ 4.53 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA